Trial Profile
Autologue PAP-loaded dendritic cell vaccine (APC8015, Provenge) in patients with non-metastatic prostate cancer who experience PSA elevation following radical prostatectomy: A randomized, controlled, double-blind trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2006
Price :
$35
*
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 Feb 2006 New trial record.